Vaccines List

Ad5-GUCY2C-PADRE is a replication-deficient human type 5 recombinant adenovirus (Ad5) vaccine encoding guanylyl cyclase C (GUCY2C) fused to the PAn DR Epitope (PADRE). GUCY2C, a paracrine hormone receptor producing the second messenger cyclic GMP (cGMP), is selectively expressed by intestinal epithelial cells and a subset of hypothalamic neurons, but not other tissues. Read more...

Adacel vaccine contains noninfectious tetanus, diphtheria, and pertussis proteins, aluminum phosphate, 2-phenoxyethanol, and residual amounts of formaldehyde and glutaraldehyde. Adacel vaccine does not contain preservatives.Read more...

 Affinivax's novel vaccine candidate, ASP3772 offers the potential to provide broader protection against pneumococcal disease. 

February 13, 2019, the first subject was dosed with ASP3772, a novel MAPS vaccine targeting Streptococcus... Read more...

AV7909 is a combination of BioThrax (also called anthrax vaccine, adsorbed or AVA), an FDA-licensed vaccine, and CPG 7909.Read more...

BG505 SOSIP.664 gp140 is a stable, soluble, cleaved HIV envelope trimer. Read more...

Boostrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria and purified proteins of pertussis bacteria. The inactive ingredients in the vaccine are aluminium hydroxide, aluminium phosphate, formaldehyde, polysorbate 80, sodium chloride (salt), glycine and water.Read more...

Boostrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria and purified proteins of pertussis bacteria.Read more...

Chikungunya Virus virus-like particle (CHIKV-VLP) vaccines are multi-protein structures that mimic the organization and conformation of naturally occurring viruses, without the viral genome, that could potentially promote a stronger immune response and increased antibody production.Read more...

Daptacel contains 15 Lf diphtheria toxoid, 5 Lf tetanus toxoid, and acellular pertussis antigens [10 µg detoxified pertussis toxin (PT), 5 µg filamentous hemagglutinin (FHA), 3 µg pertactin, and 5 µg fimbriae types 2 and 3 (FIM)] in each 0.5-mL dose.Read more...

Daptacel contains 15 Lf diphtheria toxoid, 5 Lf tetanus toxoid, and acellular pertussis antigens [10 µg detoxified pertussis toxin (PT), 5 µg filamentous hemagglutinin (FHA), 3 µg pertactin, and 5 µg fimbriae types 2 and 3 (FIM)] in each 0.5-mL dose.Read more...

Dengvaxia is a live attenuated tetravalent chimeric vaccine made using recombinant DNA technology by replacing the PrM (pre-membrane) and E (envelope) structural genes of yellow fever attenuated 17D strain vaccine with those from the four dengue serotypes.Read more...

Engerix-B a Hepatitis B Vaccine (Recombinant) is a noninfectious recombinant DNA hepatitis B vaccine.Read more...

Fluad consists of an inactivated, subunit trivalent influenza virus antigen produced in eggs and an oil-in-water emulsion adjuvant, MF59C.1.Read more...

Flublok Quadrivalent is a quadrivalent recombinant influenza vaccine. Flublok Quadrivalent consists of the four influenza strains that have been identified to be the most likely strains for the flu seasonRead more...

Flulaval Quadrivalent is a quadrivalent, split-virion, inactivated influenza virus vaccine prepared from virus propagated in the allantoic cavity of embryonated hens’ eggs. Each of the influenza viruses is produced and purified separately. The virus is inactivated with ultraviolet light treatment followed by formaldehyde treatment, purified by centrifugation, and disrupted with sodium deoxycholate.Read more...

Fluvirin is a live, attenuated or inactive virus, pathogen or toxoid of the identified flu strains for the particular flu season.Read more...

Fluzone High-Dose contains 3 killed flu virus strains. 

For the 2019 Influenza season, the 3 killed viruses were A/Michigan/45/2015 (H1N1)pdm09-like virus (A/Michigan/45/2015 X-275), A/Switzerland/8060/2017 (H3N2)- like virus (A/Brisbane/1/2018 X-311) and B/Phuket/3073/2013-like virus... Read more...

Fluzone Quadrivalent vaccine contains the 2 strains of influenza A and B identified for the current flu season contained in each vaccine.Read more...

Gardasil 9 consists of HPV proteins, Types 6, 11, 16, 18, 31, 33, 45, 52, and 58, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, Polysorbate 80, sodium borate, and water for injection.Read more...

GEN-009 is an investigational, personalized adjuvanted vaccine, that is being developed for the treatment of patients with solid tumors.Read more...

HBAI20 vaccine candidate consists of a standard HBV vaccine to which the AI20 adjuvant is added.

The adjuvant is able to give an additional stimulus to the immune system and... Read more...

HepaGam B® [Hepatitis B Immune Globulin Intravenous (Human)] is an intravenous immune globulin indicated for the following: Prevention of Hepatitis B recurrence following liver transplant in HBsAg-positive liver transplant patients.Read more...

HER-Vaxx (IMU-131) is a B-cell peptide immunotherapy cancer vaccine candidate which is constructed from several B cell epitopes derived from the extracellular domain of HER-2/neu. Read more...

HydroVax-001 is a vaccine candidate which consists of a hydrogen peroxide inactivated, whole virion (WNV-Kunjin strain) adjuvanted with aluminum hydroxide.Read more...

Imovax Rabies is an inactivated vaccine made from an attenuated rabies virus. It is a sterile, stable, freeze-dried suspension of Rabies Vaccine Inactivated virus prepared from WISTAR Rabies PM/WI 38 1503-3M strain.Read more...

Infanrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria, and purified proteins of pertussis bacteria. Each 0.5 mL dose contains: 30 IU (25 Lf U) of diphtheria toxoid.Read more...

INO-4500 is a DNA-encoded monoclonal antibody (dMAb™) vaccine candidate.Read more...

INO-A002 is a DNA-encoded monoclonal antibody (dMAb™) technology candidate.Read more...

Kinrix active ingredients are non-infectious substances from tetanus, diphtheria bacteria, and purified proteins of pertussis bacteria as well as Inactivated Poliovirus Vaccine.Read more...

mAb114 is a human IgG1 MAb targeted to the Zaire ebolavirus (EBOV) glycoprotein (GP).  mAb114 is a single monoclonal antibody which binds to the core receptor binding domain of the Zaire ebolavirus surface protein, preventing the virus from infecting human cellsRead more...

Menveo consists of two portions: 10 µg of lyophilized meningococcal serogroup A capsular polysaccharide conjugated to CRM197 and 5 μg each of capsular polysaccharide of serogroup C, W, and Y conjugated to CRM197 in 0.5 mL of phosphate-buffered saline, which is used to reconstitute the lyophilized MenA component.Read more...

M-M-R II is also known as Measles, Mumps, and Rubella Virus Vaccine Live, is a live virus vaccine, containing weakened forms of measles virus, mumps virus, and rubella virus.Read more...

Mosquirix (RTS,S/AS01) is a recombinant vaccine consisting of the P. falciparum circumsporozoite protein (CSP) from the pre-erythrocytic stage.Read more...

mRNA-1893 contains an mRNA sequence encoding for the structural proteins of the Zika virus and is designed to cause cells to secrete virus-like particles, mimicking the response of the cell after natural infection.Read more...

mRNA-4157 is a therapeutic vaccine candidate that is a combination of validated defined neoantigens, predicted neoepitopes and mutations in driver genes into a single mRNA concatemer (mRNA-4650).Read more...

MV-CHIK is a vaccine candidate utilizing Themis’ measles vector platform. MV-CHIK consists of a recombinant live Schwarz-strain measles-vectored vaccine expressing chikungunya virus structural proteins.Read more...

NanoFlu is a vaccine candidate which is a recombinant hemagglutinin (HA) protein nanoparticle influenza vaccine produced in an Sf9 insect cell-baculovirus system.Read more...

NEO-PV-01  Cancer vaccine candidate is a personal neoantigen vaccine which is custom designed and manufactured for each individual patient.Read more...

Nexvax2 is a combination of three proprietary peptides that elicit an immune response in patients with celiac disease (CeD) who carry the immune recognition gene, HLA-DQ2.5, which accounts for the condition in 80% to 90% of patients.Read more...

Pamvac is a vaccine candidate based on a recombinant fragment of VAR2CSA, the Plasmodium falciparum protein responsible for binding to the placenta via chondroitin sulfate A (CSA).Read more...

Pediarix contains noninfectious proteins from diphtheria, tetanus, and pertussis bacteria, hepatitis B virus, and inactivated polioviruses.Read more...

Pediarix contains noninfectious proteins from diphtheria, tetanus, and pertussis bacteria, hepatitis B virus, and inactivated polioviruses.Read more...

PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age.Read more...

Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis, and invasive disease due to H influenzae type b.Read more...

Pneumovax 23 is a vaccine that can help protect against infection by 23 types of pneumococcal bacteria, which are common and often cause serious illnesses.

Pneumococcal disease includes pneumococcal infections... Read more...

Priorix is a lyophilized mixed preparation of the attenuated Schwarz measles, RIT 4385 mumps (derived from Jeryl Lynn strain) and Wistar RA 27/3 rubella strains of viruses.Read more...

Priorix is a lyophilized mixed preparation of the attenuated Schwarz measles, RIT 4385 mumps (derived from Jeryl Lynn strain) and Wistar RA 27/3 rubella strains of viruses.Read more...

ProscaVax vaccine incorporates scientifically proven and clinically validated treatments for cancer.Read more...

PRV-3279 is a humanized diabody (a bispecific scaffold biologic molecule) targeting the B-cell surface proteins, CD32B and CD79B, which has the potential to intercept the pathophysiology of systemic lupus erythematosus (SLE) and other B cell-mediated autoimmune diseases.Read more...

RabAvert is a vaccine that contains an inactivated rabies antigen.Read more...

Redeeflu™ nasal vaccine candidate utilizes a proprietary M2 deleted, single replication (M2SR) influenza virus.

The M2 gene is essential for the influenza virus to spread in the patient and the... Read more...

RH5.1/AS01 is a vaccine candidate that make many different types of antibodies against the same RH5 protein target. 

The malaria parasite's protein, RH5, must bind to a human protein on... Read more...

Rotarix (Rotavirus Vaccine, Live, Oral), for oral administration, is a live, attenuated rotavirus vaccine derived from the human 89-12 strain which belongs to G1P[8] type.

This rotavirus strain is propagated on Vero... Read more...

Sabin IPV is a liquid trivalent vaccine produced from Sabin poliovirus type 1, 2, and 3 strains grown on Vero cells. 

This vaccine is indicated to prevent Wild Polio Virus, in... Read more...

SCIB1 is a cancer vaccine candidate that is being developed for the treatment of melanoma.Read more...

Shingrix is an adjuvanted recombinant zoster vaccine, consisting of the varicella-zoster virus glycoprotein E antigen and the AS01B adjuvant system, a proprietary adjuvant containing QS-21 and MPL with liposomes.Read more...

Stamaril is a live, attenuated vaccine that contains the active substance Yellow fever virus1 17D-204 strain produced in specified pathogen-free chick embryos.Read more...

TAK-003 is an investigational live-attenuated tetravalent dengue vaccine, preventing dengue fever caused by any of the four serotypes of the dengue virus. Takeda's tetravalent dengue vaccine candidate TAK-003 is based on a live-attenuated dengue serotype 2 virus, which provides the genetic “backbone” for all four vaccine viruses.Read more...

TAK-426 (PIZV) is a purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate.Read more...

Tipapkinogen Sovacivec is a therapeutic vaccine candidate which has inserted genes that code for three proteins: human cytokine IL-2 and modified forms of HPV 16 E6 and E7 proteins that have been rendered non-oncogenic.  It utilizes the modified vaccinia virus Ankara (MVA) which is a highly attenuated replication-deficient strain of vaccinia virus as the gene-delivery system.Read more...

Trumenba is a sterile suspension composed of two recombinant lipidated factor H binding protein (fHBP) variants from N. meningitidis serogroup B, one from fHBP subfamily A and one from subfamily B (A05... Read more...

Twinrix is a bivalent vaccine containing the antigenic components used in producing HAVRIX (strain HM175) and ENGERIX-B [noninfectious hepatitis B virus surface antigen (HBsAg).].Read more...

TY014 will be the first therapeutic in the world, specifically targeting Yellow Fever Virus (YFV), to enter clinical trials. It is anticipated that a monoclonal antibody therapeutic could be administered... Read more...

TYPHIM Vi is manufactured by Sanofi Pasteur for intramuscular use for protection against Typhoid Fever.Read more...

V114 is Merck’s investigational 15-valent pneumococcal conjugate vaccine in Phase 3 development for the prevention of pneumococcal disease in adults and children.

V114 consists of pneumococcal polysaccharides from 15 serotypes... Read more...

Vaqta is an inactivated whole virus vaccine derived from hepatitis A virus grown in cell culture in human MRC-5 diploid fibroblasts. It contains inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain.Read more...

VARIZIG [Varicella Zoster Immune Globulin (Human)] is indicated in the United States for post-exposure prophylaxis of varicella (chickenpox) in high risk patient groups including immunocompromised children, newborns, and pregnant women.Read more...

VAXELIS is a pediatric Hexavalent vaccine which includes antigens for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis from Sanofi and antigens for H. influenzae type b and hepatitis B from Merck. 

VAXELIS is indicated... Read more...

VCL-HB01 is a therapeutic HSV plasmid DNA vaccine candidate formulated with Vaxfectin.

February 25, 2019 Recruitment Status of the Phase 2 clinical trial was updated to reflect the Study Status as completed... Read more...

Vivotif is an oral vaccine for typhoid fever, a potentially severe and life-threatening infection caused by the bacterium Salmonella enterica serotype Typhi (S Typhi).Read more...

VLA1553 is a monovalent, single dose, live-attenuated vaccine candidate.Read more...

VPM1002 is a formulated, lyophilized cake of live recombinant Mycobacterium bovis rBCGÄureC::Hly+; VPM1002.   

VPM1002 is the active pharmaceutical ingredient. It is a genetically modified BCG vaccine derived from the... Read more...

VXA-G1.1-NN is an Oral Vaccine Candidate Tablet addressing Norovirus.Read more...

YF-VAX is prepared by culturing the 17D-204 strain of yellow fever virus in living avian leukosis virus-free (ALV-free) chicken embryos. The vaccine contains sorbitol and gelatin as a stabilizer, is lyophilized, and is hermetically sealed under nitrogen.Read more...